Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome
Recommended Citation
Hencken L, To L, Ly N, Morgan JA. Serotonin syndrome following methylene blue administration for vasoplegic syndrome. J Card Surg. Apr 2016;31(4):208-210.
Document Type
Article
Publication Date
4-1-2016
Publication Title
Journal of cardiac surgery
Abstract
Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management.
Medical Subject Headings
Citalopram; Drug Synergism; Female; Heart-Assist Devices; Humans; Methylene Blue; Middle Aged; Prosthesis Implantation; Serotonin Syndrome; Serotonin Uptake Inhibitors; Severity of Illness Index; Vasoplegia
PubMed ID
26934199
Volume
31
Issue
4
First Page
208
Last Page
210